Analyst Reco. Embecta Corp.

Equities

EMBC

US29082K1051

Delayed Nasdaq Other stock markets 03:52:55 2024-05-20 pm EDT			5-day change	1st Jan Change
13.94 ^USD	-3.53%		-1.69%	-26.36%

May. 16	Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
May. 09	Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Price Target on to $16 From $15, Maintains Underweight Rating	Nov. 22	MT
Morgan Stanley Adjusts Price Target on Embecta to $15 From $16, Maintains Underweight Rating	23-10-18	MT
BofA Trims Price Target on Embecta to $17 From $25, Keeps Underperform Rating	23-10-18	MT
Morgan Stanley Trims Price Target on Embecta to $16 From $19, Maintains Underweight Rating	23-08-24	MT
Morgan Stanley Adjusts Price Target on Embecta to $19 From $29, Maintains Underweight Rating	23-07-18	MT
Morgan Stanley Downgrades Embecta to Underweight From Equalweight, Price Target is $28	23-01-06	MT
Morgan Stanley Adjusts Price Target on Embecta to $31 From $33, Maintains Equal-Weight Rating	22-12-21	MT
Morgan Stanley Adjusts Price Target on Embecta Corp. to $33 From $36, Reiterates Equalweight Rating	22-10-11	MT
BTIG Initiates Embecta at Neutral	22-09-08	MT
Morgan Stanley Adjusts Price Target on Embecta to $36 From $33, Keeps Equalweight Rating	22-08-16	MT
Morgan Stanley Initiates Embecta at Equalweight with $33 Price Target	22-08-01	MT
BofA Securities Initiates Embecta at Underperform with $25 Price Target	22-06-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW